Skip to main content
. Author manuscript; available in PMC: 2022 Jan 11.
Published in final edited form as: Mol Pharm. 2021 Jul 14;18(8):2889–2905. doi: 10.1021/acs.molpharmaceut.1c00455

Figure 4.

Figure 4.

Design and proposed mechanism of PNP-D-mAb. (A) The structure of the cholesterol-modified CPP. (B) Schematic illustration of the nanoparticle formation process including peptide self-assembling, drug loading, and mAb modification. (C) The proposed mechanism of PNP-D-mAb in CAFs targeting and drug penetration. Adapted with permission from ref 97. copyright (2015) Wiley.